Current
—
5-Year Average
—
All-Time High
—
All-Time Low
—
P/S Ratio daily chart for Kodiak Sciences (KOD)
Jun 14, 2021 – Jun 12, 2026 · 1,256 trading days
P/S ratio is not shown for periods when TTM revenue was negative.
Historical P/S Ratio for Kodiak Sciences (KOD) from 2017 to 2025
| 2025 | $1.49B | $0.00 | — | — | |
| 2024 | $523.87M | $0.00 | — | — | |
| 2023 | $159.55M | $0.00 | — | — | |
| 2022 | $374.59M | $0.00 | — | — | |
| 2021 | $881.73M | $0.00 | — | — | |
| 2020 | $1.41B | $0.00 | — | — | |
| 2019 | $568.72M | $0.00 | — | — | |
| 2018 | $51.65M | $0.00 | — | — | |
| 2017 | $53.91M | $0.00 | — | — |
- 2025—
- 2024—
- 2023—
- 2022—
- 2021—
- 2020—
- 2019—
- 2018—
- 2017—
About P/S Ratio at Kodiak Sciences (KOD)
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Kodiak Sciences (KOD), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.4× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Kodiak Sciences (KOD) Key Financials
Charts, filings, and peer comparison for every metric